Taro Pharmaceutical Indus Q3 EPS $0.19 May Not Compare To $0.87 Estimate, Sales $139.20M Miss $163.12M Estimate
Author: Michael Horton | January 24, 2023 06:45pm
Taro Pharmaceutical Indus (NYSE:
TARO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.87 by 78.16 percent. This is a 72.86 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $139.20 million which missed the analyst consensus estimate of $163.12 million by 14.66 percent. This is a 0.15 percent increase over sales of $139.00 million the same period last year.
Posted In: TARO